Last reviewed · How we verify

NCT06142734

Laparoscopic Versus Open Pyeloplasty for Treatment of UPJO in Children.

Status unknown NA Last updated 21 November 2023
What this trial tests

NA trial testing pyeloplasty in Pyeloplasty in 40 participants. Status unknown.

Timeline
1 January 2024
Primary endpoint
1 January 2026
1 January 2026

Quick facts

Lead sponsorAhmed Mahmoud Abdelraouf
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 January 2024
Primary completion1 January 2026
Estimated completion1 January 2026

Drugs / interventions tested

Conditions studied

Sponsor

Ahmed Mahmoud Abdelraouf

Who can join

Adults 1 to 18, any sex, with Pyeloplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Uretropelvic junction ( UPJ ) obstruction is a common congenital disorder , but not all cases require surgical intervention. Uretropelvic junction ( UPJ ) obstruction is a common congenital disorder , but not all cases require surgical intervention. On the other hand, in children many authors reported mini incision open pyeloplasty with very small subcostal muscle splitting incision, with negligible postoperative pain and very short hospital stay

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of pyeloplasty

Trials testing the same drug.

Other recruiting trials for Pyeloplasty

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06142734.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing